The role of growth factor receptor pathways in human breast cancer cells adapted to long-term estrogen deprivation.

Abstract:

:To study the long-term effects of estrogen deprivation on breast cancer, MCF-7Ca human estrogen receptor-positive breast cancer cells stably transfected with human aromatase gene were cultured in the steroid-depleted medium for 6 to 8 months until they had acquired the ability to grow. Proliferation of these cells (UMB-1Ca) was accompanied by increased expression of human epidermal growth factor receptor 2, increased activation of AKT through phosphorylation at Ser473 and Thr308, and increased invasion compared with parental MCF-7Ca cells. Estrogen receptor expression was also increased 5-fold. Although growth was inhibited by the antiestrogen fulvestrant, the IC50 was 100-fold higher than for parental MCF-7Ca cells. Aromatase inhibitor letrozole also inhibited growth at 10,000-fold higher concentration than required for MCF-7Ca cells, whereas anastrozole, exemestane, formestane, and tamoxifen were ineffective at 100 nmol/L. Growth of UMB-1Ca cells was inhibited by phosphatidylinositol 3-kinase inhibitor wortmannin (IC50 approximately 25 nmol/L) and epidermal growth factor receptor kinase inhibitor gefitinib (ZD 1839; IC50 approximately 10 micromol/L) whereas parental MCF-7Ca cells were insensitive to these agents. Concomitant treatment of UMB-1Ca cells with the signal transduction inhibitors and anastrozole and tamoxifen restored their growth inhibitory effects. These studies show that estrogen deprivation results in up-regulation of growth factor signaling pathways, which leads to a more aggressive and hormone refractory phenotype. Cross-talk between ER and growth factor signaling was evident as inhibition of these pathways could restore estrogen responsiveness to these cells.

journal_name

Cancer Res

journal_title

Cancer research

authors

Sabnis GJ,Jelovac D,Long B,Brodie A

doi

10.1158/0008-5472.CAN-04-4092

subject

Has Abstract

pub_date

2005-05-01 00:00:00

pages

3903-10

issue

9

eissn

0008-5472

issn

1538-7445

pii

65/9/3903

journal_volume

65

pub_type

杂志文章
  • Mechanism of activation of human ras genes cloned from a gastric adenocarcinoma and a pancreatic carcinoma cell line.

    abstract::We have analyzed the mechanism of activation of two human ras oncogenes. We have also identified a rasN gene from a human gastric adenocarcinoma which efficiently induced both morphological transformation and tumorigenicity of NIH3T3 cells in a transfection assay. The rasN gene in tumor tissue DNA did not appear to be...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: O'Hara BM,Oskarsson M,Tainsky MA,Blair DG

    更新日期:1986-09-01 00:00:00

  • Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.

    abstract::9-beta-D-Arabinofuranosyl-2-fluoroadenine (2-F-ara-A), a derivative of 9-beta-D-arabinofuranosyladenine (ara-A) that is resistant to deamination, selectively inhibits DNA synthesis and has activity against mouse leukemia L1210 comparable to that of ara-A plus the adenosine deaminase inhibitor, 2'-deoxycoformycin. To d...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: White EL,Shaddix SC,Brockman RW,Bennett LL Jr

    更新日期:1982-06-01 00:00:00

  • A novel method for the detection of necrotic lesions in human cancers.

    abstract::Data are presented in support of the hypothesis that malignant tumors, containing abnormally permeable, degenerating cells, can be selectively detected using monoclonal antibodies to intracellular antigens. Biodistribution, imaging, and autoradiographic studies were performed in nude mice transplanted with four differ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Epstein AL,Chen FM,Taylor CR

    更新日期:1988-10-15 00:00:00

  • An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer.

    abstract::Breast cancer has been redefined into three clinically relevant subclasses: (i) estrogen/progesterone receptor positive (ER+/PR+), (ii) HER2/ERRB2 positive, and (iii) those lacking expression of all three markers (triple negative or basal-like). While targeted therapies for ER+/PR+ and HER2+ tumors have revolutionized...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-1098

    authors: McCleland ML,Adler AS,Shang Y,Hunsaker T,Truong T,Peterson D,Torres E,Li L,Haley B,Stephan JP,Belvin M,Hatzivassiliou G,Blackwood EM,Corson L,Evangelista M,Zha J,Firestein R

    更新日期:2012-11-15 00:00:00

  • Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody.

    abstract::Immunohistochemical localization of estrogen receptor (ER) using specific monoclonal anti-human estrogen receptor antibody, H222, with an immunoperoxidase technique was performed on fresh frozen tissue derived from 100 endometrial adenocarcinomas. Immunohistochemical evaluation incorporated both intensity and distribu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Budwit-Novotny DA,McCarty KS,Cox EB,Soper JT,Mutch DG,Creasman WT,Flowers JL,McCarty KS Jr

    更新日期:1986-10-01 00:00:00

  • An RNA interference screen identifies metabolic regulators NR1D1 and PBP as novel survival factors for breast cancer cells with the ERBB2 signature.

    abstract::Overexpression of the adverse prognostic marker ERBB2 occurs in 30% of breast cancers; however, therapies targeting this gene have not proved to be as effective as was initially hoped. Transcriptional profiling meta-analyses have shown that there are approximately 150 genes co-overexpressed with ERBB2, suggesting that...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-1550

    authors: Kourtidis A,Jain R,Carkner RD,Eifert C,Brosnan MJ,Conklin DS

    更新日期:2010-03-01 00:00:00

  • Breast cancer stem cells: something out of notching?

    abstract::We and others have established that the developmental Notch receptor signaling pathway is active in breast cancer cell lines, as well as in preinvasive and invasive primary samples. Recently, a role for Notch in regulating the hierarchy of stem and progenitor cells in both normal and cancer epithelium has been elucida...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-10-1559

    authors: Harrison H,Farnie G,Brennan KR,Clarke RB

    更新日期:2010-11-15 00:00:00

  • Pharmacokinetics of 111In-labeled OC-125 antibody in cancer patients compared with the 19-9 antibody.

    abstract::We recently reported on the pharmacokinetics in 14 cancer patients of the 19-9 antibody radiolabeled with 111In. We have now repeated this investigation in 18 cancer patients using the OC-125 antibody, in part to compare the in vivo behavior of two murine monoclonal antibodies of the same subclass administered as the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hnatowich DJ,Gionet M,Rusckowski M,Siebecker DA,Roche J,Shealy D,Mattis JA,Wilson J,McGann J,Hunter RE

    更新日期:1987-11-15 00:00:00

  • Evidence that cutaneous carcinogen-initiated epithelial cells from mice are quiescent rather than actively cycling.

    abstract::The basal layer of the epidermis and hair follicles is composed of actively cycling, transit-amplifying cells and quiescent cells including stem cells. To determine which population is the target of carcinogenic chemicals, we treated CD-1 female mice topically with 5-fluorouracil (5-FU), an agent known to kill cycling...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Morris RJ,Coulter K,Tryson K,Steinberg SR

    更新日期:1997-08-15 00:00:00

  • Mutation induction by 5-fluorodeoxyuridine in synchronous Chinese hamster cells.

    abstract::Chinese hamster ovary cells synchronized by mitotic detachment were treated with 5-fluorodeoxyuridine (FdUrd), 0.2 micrograms/ml, at various times in the cell cycle. FdUrd treatment in the early S period induced resistance to 6-thioguanine. Treatment of asynchronous cells with FdUrd caused little increase in 6-thiogua...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Aebersold PM

    更新日期:1979-03-01 00:00:00

  • IkappaB kinase-alpha regulates endothelial cell motility and tumor angiogenesis.

    abstract::The transcription factor nuclear factor-kappaB (NF-kappaB) is constitutively activated in many types of cancers and has been implicated in gene expression important for angiogenesis, tumor growth, progression, and metastasis. Here, we show that the NF-kappaB activator, IkappaB kinase-alpha (IKKalpha), but not IKKbeta,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-1833

    authors: DeBusk LM,Massion PP,Lin PC

    更新日期:2008-12-15 00:00:00

  • Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice.

    abstract::Groups of 15 mice of three different laboratory strains (BALB/c, C3H/He, DBA/2) were fed on a low iron diet (5 mg iron/kg diet), and three similar groups of 15 mice were maintained on a normal iron diet (312 mg iron/kg diet). When the low iron diet group became iron deficient, tumor cells (5 x 10(5) cells/mouse) of CA...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hann HW,Stahlhut MW,Blumberg BS

    更新日期:1988-08-01 00:00:00

  • Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study.

    abstract::The amount of iododeoxyuridine (IdUrd) incorporated into DNA determines the degree of radiosensitization. Fluorodeoxyuridine (FdUrd) has been shown to biochemically modulate IdUrd incorporation into DNA in vitro and in vivo. In this Phase I study, these drugs were coadministered to patients during 14-day continuous i....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Speth PA,Kinsella TJ,Belanger K,Klecker RW Jr,Smith R,Rowland JB,Collins JM

    更新日期:1988-05-15 00:00:00

  • Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias.

    abstract::The BCR/ABL fusion protein is a constitutively active tyrosine kinase that is responsible for the pathogenesis of chronic myelogenous leukemia (CML). Clinically, CML is characterized by a chronic phase (CP) that eventually terminates into a blast crisis (BC). BC transformation is associated with accumulation of CD34+ ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bonati A,Carlo-Stella C,Lunghi P,Albertini R,Pinelli S,Migliaccio E,Sammarelli G,Savoldo B,Tabilio A,Dall'Aglio PP,Pelicci PG

    更新日期:2000-02-01 00:00:00

  • Identification of the major protein components in breast secretions from women with benign and malignant breast diseases.

    abstract::The protein composition of breast secretions from 99 premenopausal women with benign or malignant breast diseases and from 70 control women without breast pathologies has been studied by using polyacrylamide gel electrophoresis. These fluids have been classified into two types according to their major polypeptide comp...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sánchez LM,Vizoso F,Díez-Itza I,López-Otín C

    更新日期:1992-01-01 00:00:00

  • Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.

    abstract::Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD) could function as a cell surface sensor for cell density, controlling the transition between local cell proliferation and tissue invasion in melanoma progression. We have tested the hypothesis that progressive cell clustering controls the proteolytic cascad...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0378

    authors: Lunter PC,van Kilsdonk JW,van Beek H,Cornelissen IM,Bergers M,Willems PH,van Muijen GN,Swart GW

    更新日期:2005-10-01 00:00:00

  • Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients.

    abstract::We postulated that increased expression of the cell cycle regulators cyclin D1 and cyclin-dependent kinase (Cdk) 4 may be involved in the development of intestinal adenomas associated with familial adenomatous polyposis (FAP). In the present study of multiple intestinal neoplasia (Min) mice and human FAP patients, the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Zhang T,Nanney LB,Luongo C,Lamps L,Heppner KJ,DuBois RN,Beauchamp RD

    更新日期:1997-01-01 00:00:00

  • Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3.

    abstract::Telomerase is essential for immortalization of most human cancer cells. Expression of the core telomerase RNA (hTR) and reverse transcriptase (hTERT) subunits is mainly regulated by transcription. However, hTR transcriptional regulation remains poorly understood. We previously showed that the core hTR promoter is acti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1941

    authors: Bilsland AE,Stevenson K,Atkinson S,Kolch W,Keith WN

    更新日期:2006-02-01 00:00:00

  • Immune selection and emergence of aggressive tumor variants as negative consequences of Fas-mediated cytotoxicity and altered IFN-gamma-regulated gene expression.

    abstract::Antitumor responses can be induced in patients via active or adoptive immunotherapy, yet complete tumor eradication occurs infrequently. This paradox in tumor immunology led us to address two questions: (a) Does an antitumor response, which is intended to destroy the aberrant target population, also at the same time s...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-4269

    authors: Liu K,Caldwell SA,Abrams SI

    更新日期:2005-05-15 00:00:00

  • Identification of Oncogenic and Drug-Sensitizing Mutations in the Extracellular Domain of FGFR2.

    abstract::The discovery of oncogenic driver mutations and the subsequent developments in targeted therapies have led to improved outcomes for subsets of lung cancer patients. The identification of additional oncogenic and drug-sensitive alterations may similarly lead to new therapeutic approaches for lung cancer. We identify an...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-3771

    authors: Tanizaki J,Ercan D,Capelletti M,Dodge M,Xu C,Bahcall M,Tricker EM,Butaney M,Calles A,Sholl LM,Hammerman PS,Oxnard GR,Wong KK,Jänne PA

    更新日期:2015-08-01 00:00:00

  • Regulation of endogenous murine leukemia virus-related nuclear and cytoplasmic RNA complexity in C57BL/6J mice of increasing age.

    abstract::The nucleotide sequence complexity of murine leukemia virus *MuLV)-related RNA has been measured by RNA-complementary DNA hybridization analysis in nuclear and cytoplasmic RNA isolated from liver and brain of low-leukemia-strain C57BL/6J mice of different ages. In these two tissues, an approximate 1.5- to 2-fold incre...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Florine DL,Ono T,Cutler RG,Getz MJ

    更新日期:1980-03-01 00:00:00

  • Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.

    abstract::Hepatocellular carcinoma is among the most common and lethal cancers in humans. Hepatocellular carcinoma is commonly associated with physical or functional inactivation of the p53 tumor suppressor, high levels of chromosomal instability, and disease conditions causing chronic cycles of hepatocyte death and regeneratio...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-4608

    authors: Farazi PA,Glickman J,Horner J,Depinho RA

    更新日期:2006-05-01 00:00:00

  • Effects of the antitumor agent 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one on the DNA of mouse L1210 cells.

    abstract::L1210 murine leukemia cells were treated in vitro with the novel antineoplastic agent 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d] -1,2,3,5-tetrazin-4(3H)-one (M&B 39565), and its interaction with cellular DNA was assessed by alkaline elution. DNA interstrand cross-link and DNA-protein cross-link formation was quantifi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gibson NW,Erickson LC,Hickman JA

    更新日期:1984-05-01 00:00:00

  • Effects of 1,2-symmetrical dimethylhydrazine on jejunocolic transposition in Sprague-Dawley rats.

    abstract::In this experiment, a segment of the left colon including the upper part of the rectum was transposed to the upper jejunum, and a segment of upper jejunum was transposed to the left colon of the same animal. In another group, the same colon and jejunum segments were transsected and reanastomosed in place. A third grou...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Celik C,Mittelman A,Paolini NS Jr,Lewis D,Evans JT

    更新日期:1981-07-01 00:00:00

  • Importance of tumor-specific cytotoxic CD8+ T-cells in eradication of a large subcutaneous MOPC-315 tumor following low-dose melphalan therapy.

    abstract::We have previously demonstrated that depletion of CD8+ T-cells by the use of a monoclonal anti-Lyt-2.2 antibody abolishes the curative effectiveness of low-dose melphalan (L-phenylalanine mustard; L-PAM) therapy for BALB/c mice bearing a large (greater than or equal to 20 mm) s.c. MOPC-315 tumor and extensive metastas...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Takesue BY,Pyle JM,Mokyr MB

    更新日期:1990-12-01 00:00:00

  • Comparison of virus-positive and virus-negative cases of feline leukemia and lymphoma.

    abstract::One hundred eighty-four cases of feline leukemia and lymphoma diagnosed in Boston from 1972 through 1976 were investigated. Fifty-eight % of these cases were lymphoma, and 42% were leukemia. Sixty-seven % of the cats had positive fluorescent antibody tests for circulating feline leukemia virus. The rest (33%) were vir...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Francis DP,Cotter SM,Hardy WD Jr,Essex M

    更新日期:1979-10-01 00:00:00

  • Loss of annexin II heavy and light chains in prostate cancer and its precursors.

    abstract::Annexin II mRNA coding for a calcium binding protein was found to be absent in prostate cancer by subtractive hybridization and Northern analysis. In contrast to high expression in normal and benign hyperplastic glandular and basal epithelium, Annexin II heavy (p36) and light (p11) chains in 31/31 prostate cancer spec...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chetcuti A,Margan SH,Russell P,Mann S,Millar DS,Clark SJ,Rogers J,Handelsman DJ,Dong Q

    更新日期:2001-09-01 00:00:00

  • Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.

    abstract::Previous electrophoretic analysis has indicated that keratins 13 and 16 (K13 and K16) are not present in normal human breast epithelium, but K16 is expressed in some ductal carcinomas (Moll et al., Cell, 31: 11-24, 1982). K16 may thus represent a marker for identifying a subset of ductal carcinomas and for distinguish...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pellegrino MB,Asch BB,Connolly JL,Asch HL

    更新日期:1988-10-15 00:00:00

  • Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.

    abstract::Progression of prostate cancer is believed to be dependent on angiogenesis induced by tumor cells. 3,3'-Diindolylmethane (DIM) has been shown to repress neovascularization in a Matrigel plug assay and inhibit cell proliferation, migration, invasion, and capillary tube formation of cultured human umbilical vein endothe...

    journal_title:Cancer research

    pub_type: 杂志文章,收录出版

    doi:10.1158/0008-5472.CAN-06-4277

    authors: Kong D,Li Y,Wang Z,Banerjee S,Sarkar FH

    更新日期:2007-04-01 00:00:00

  • Action of a novel anticancer agent, CHS 828, on mouse fibroblasts: increased sensitivity of cells lacking poly (ADP-Ribose) polymerase-1.

    abstract::We observed stronger cytotoxic effect of CHS 828 on poly(ADP-ribose) polymerase-1(PARP-1) knock-out cells as compared with the normal counterpart. The proliferation of PARP-1 -/- cells was inhibited by a drug concentration approximately 3-fold lower than that in the normal cells. The monitoring of p53 levels revealed ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lövborg H,Wojciechowski J,Larsson R,Wesierska-Gadek J

    更新日期:2002-08-01 00:00:00